Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares 7-10 Year Treasury Bond ETF
IEF
$46.8B
| $1.27B | 0.9% |
12,459,743
+110,380
| +0.9% | +$11.3M |
|
27
Thermo Fisher Scientific
TMO
$196B
| $1.27B | 0.9% |
2,340,814
+83,936
| +4% | +$46.2M |
|
28
NextEra Energy
NEE
$184B
| $1.26B | 0.89% |
16,228,364
+564,306
| +4% | +$43M |
|
29
PayPal
PYPL
$42B
| $1.21B | 0.86% |
17,329,942
+552,397
| +3% | +$47.9M |
|
30
Oracle
ORCL
$379B
| $1.21B | 0.86% |
17,301,215
+542,384
| +3% | +$39.7M |
|
31
NVIDIA
NVDA
$4.93T
| $1.15B | 0.81% |
75,911,860
+2,628,140
| +4% | +$49.6M |
|
32
Netflix
NFLX
$311B
| $1.15B | 0.81% |
65,483,030
+1,922,090
| +3% | +$42.6M |
|
33
Union Pacific
UNP
$172B
| $1.12B | 0.79% |
5,258,523
+149,603
| +3% | +$34M |
|
34
Merck
MRK
$306B
| $1.11B | 0.78% |
12,123,820
+291,723
| +2% | +$25.9M |
|
35
Shell
SHEL
$233B
| $1.06B | 0.75% |
20,255,325
+659,109
| +3% | +$37M |
|
36
Abbott
ABT
$160B
| $1.02B | 0.72% |
9,390,366
+276,309
| +3% | +$31.4M |
|
|
37
Johnson & Johnson
JNJ
$621B
| $1.02B | 0.72% |
5,729,930
+5,091,698
| +798% | +$907M |
|
38
BHP
BHP
$207B
| $1.01B | 0.72% |
18,027,616
-922,776
| -5% | -$57.3M |
|
39
Goldman Sachs
GS
$309B
| $976M | 0.69% |
3,286,827
+113,329
| +4% | +$35.3M |
|
40
Chevron
CVX
$363B
| $976M | 0.69% |
6,739,795
+158,766
| +2% | +$26.2M |
|
41
Danaher
DHR
$142B
| $973M | 0.69% |
4,330,431
+105,929
| +3% | +$24.4M |
|
42
Novartis
NVS
$293B
| $951M | 0.67% |
11,246,080
+375,047
| +3% | +$32.9M |
|
43
Intuitive Surgical
ISRG
$144B
| $923M | 0.65% |
4,600,358
+108,521
| +2% | +$25.5M |
|
44
Intuit
INTU
$79.3B
| $907M | 0.64% |
2,352,591
+186,794
| +9% | +$77.3M |
|
45
Rio Tinto
RIO
$146B
| $906M | 0.64% |
14,846,876
+717,951
| +5% | +$51.5M |
|
46
JPMorgan Chase
JPM
$896B
| $900M | 0.64% |
7,989,439
+229,353
| +3% | +$28.4M |
|
47
Sanofi
SNY
$105B
| $881M | 0.62% |
17,612,672
-320,069
| -2% | -$17M |
|
48
Verizon
VZ
$178B
| $880M | 0.62% |
17,336,618
+549,117
| +3% | +$27.8M |
|
49
Nike
NKE
$64.8B
| $873M | 0.62% |
8,541,187
+256,322
| +3% | +$30.3M |
|
50
GSK
GSK
$105B
| $852M | 0.6% |
15,654,499
+480,732
| +3% | +$26.5M |
|
Similar funds
